| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693757 | The Breast | 2017 | 7 Pages |
Abstract
High percentage of patients with luminal-like MBC received CT as first-line therapy in real-life. The choice was mainly driven by age and site of metastases. With the limitations of a non-randomized comparison, no differences on patients' outcome were observed depending on the first-line strategy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Marta Bonotto, Lorenzo Gerratana, Massimo Di Maio, Carmine De Angelis, Marika Cinausero, Stefano Moroso, Monica Milano, Brigida Stanzione, Piera Gargiulo, Donatella Iacono, Alessandro Marco Minisini, Mauro Mansutti, Gianpiero Fasola, Sabino De Placido,